GlassScriptPhysician profile
Robert Merrill
NPI 1891225405
$5,586.26
in general payments reported to CMS, 2019-2025
12 companies · $442 in 2025
The $442 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,390 · 2023: $2,002 · 2024: $1,753 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,709 · Travel and Lodging: $1,488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,708.66 |
| Travel and Lodging | $1,488.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,343.32 | 2022-2025 | Everest Spinal System, Air, Avs Navigator |
| Nuvasive, INC. | $1,221.53 | 2023 | Acp, Modulus, Pulse |
| Medtronic, INC. | $896.58 | 2022-2024 | Unid_pass, Cd Horizon Spinal System |
| Globus Medical, INC. | $375.94 | 2023-2025 | Excelsiusgps Robotic Navigation System, Coalition Mis / Mis Ti, Attrax |
| Depuy Synthes Sales INC. | $256.71 | 2023-2025 | Teligen, Conduit, Fibergraft Aeridyan Matrix |
| Si-Bone, INC. | $230.84 | 2023-2024 | |
| Nevro Corp. | $110.00 | 2023 | Senza |
| Biocomposites INC | $55.33 | 2024 | |
| Zimvie INC. | $31.02 | 2024 | |
| Zimmer Biomet Holdings, INC. | $25.76 | 2023 | Biomet Spinalpak / Orthopak, Spf-Xl Iib Implantable Spinal Fusion Stimulator |
| Gotham Surgical Solutions & Devices, INC. | $23.29 | 2025 | |
| Orthofix Medical, INC. | $15.94 | 2024 | Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Merrill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.